Upgrade to SI Premium - Free Trial

Amicus Therapeutics (FOLD) Tops Q3 EPS by 8c, Revenues Miss; Raises FY19 Galafold Revenue Guidance

November 11, 2019 7:02 AM
Amicus Therapeutics (NASDAQ: FOLD) reported Q3 EPS of ($0.24), $0.08 better than the analyst estimate of ($0.32). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News Earnings Guidance Hot Guidance Management Comments

Next Articles